PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Axioms0 citationsOpen Access

A Genotype-Structured PDE Model of Vaccine-Induced Control of Variant Emergence

ABAnass BouchnitaBDBehzad Djafari-Rouhani

Key Points

  • The research aims to quantify how different vaccine compositions affect variant emergence and public health outcomes.
  • Developed a genotype-structured transmission model incorporating vaccination
  • Analyzed variant emergence dynamics with and without vaccination
  • Simulated effects of various vaccine formulations on infection rates and variant evolution
  • Compared performance of M-triangular versus triangular vaccine compositions
  • Narrow-spectrum vaccines reduce initial infections but increase variant emergence
  • M-triangular vaccines limit secondary variant expansion compared to triangular
  • Broader cross-protection vaccines are more effective in managing variant emergence
  • Antigenic targeting between co-circulating variants shows greater benefits for broader vaccines.

Abstract

Variant emergence continues to pose a threat to public health, despite the widespread use of vaccination. To quantify how vaccine strain compositions shape evolutionary and epidemiological outcomes, we extend a previous genotype-structured transmission model with vaccination and study the impact of different vaccination formulations on variant emergence. It consists of a set of partial differential equations coupled with an integro-differential one. We begin by showing that the model reproduces variant emergence followed by a period of co-circulation in the absence of vaccination. Then, we introduce vaccination and show important trade-offs shaped by the breadth and cross-protection of vaccine-induced immunity. In our simulations, narrow-spectrum vaccines substantially reduce the immediate infection burden but inadvertently promote the emergence of non-targeted variants. After that, we study the effects of more complex shapes such as triangular and M-shaped configurations. We show that M-triangular distributions outperform triangular ones by limiting secondary variant expansion for vaccines with narrow cross-protection. In contrast, triangular compositions are more protective when considering broader cross-protection. We also show that targeting the genetic area between co-circulating variants is more beneficial than focusing on specific variants when using vaccines with a broad cross-protection. Together, these results highlight how vaccine breadth and antigenic targeting influence both epidemic size and the trajectory of variant emergence, offering quantitative guidance for monovalent and multivalent vaccine design.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bouchnita et al. (2026) studied this question.

synapsesocial.com/papers/698d6f0d5be6419ac0d55112https://doi.org/10.3390/axioms15020128
Ask AI
Helpful
Bookmark
Share
View Full Paper